
AngioDynamics ANGO
$ 11.1
-0.89%
Quarterly report 2026-Q1
added 04-02-2026
AngioDynamics Total Shareholders Equity 2011-2026 | ANGO
Annual Total Shareholders Equity AngioDynamics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 183 M | 206 M | 378 M | 424 M | 439 M | 455 M | 615 M | 543 M | 515 M | 507 M | 545 M | 537 M | 526 M | 523 M | 406 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 615 M | 183 M | 453 M |
Quarterly Total Shareholders Equity AngioDynamics
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 173 M | 179 M | 183 M | 186 M | 187 M | 197 M | 206 M | 219 M | 401 M | 428 M | 378 M | 398 M | 408 M | 414 M | 424 M | 430 M | 432 M | 436 M | 439 M | 436 M | 454 M | 454 M | 454 M | 455 M | 614 M | 614 M | 614 M | 614 M | 550 M | 550 M | 550 M | 545 M | 521 M | 518 M | 515 M | 515 M | 523 M | 513 M | 507 M | 507 M | 548 M | 547 M | 548 M | 547 M | 543 M | 540 M | 544 M | 540 M | 530 M | 528 M | 526 M | 527 M | 527 M | 524 M | 523 M | 524 M | 411 M | 409 M | 406 M | 406 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 614 M | 173 M | 456 M |
Total Shareholders Equity of other stocks in the Medical instruments industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
243 K | - | - | $ 810 M | ||
|
iRhythm Technologies
IRTC
|
153 M | $ 122.35 | 0.73 % | $ 3.92 B | ||
|
Alcon
ALC
|
18.8 B | $ 75.8 | -0.08 % | $ 40.4 B | ||
|
Repro Med Systems
KRMD
|
17 M | $ 3.96 | -0.75 % | $ 183 M | ||
|
Ekso Bionics Holdings
EKSO
|
9.03 M | $ 10.99 | 1.48 % | $ 26.7 M | ||
|
The Cooper Companies
COO
|
8.24 B | $ 64.42 | -0.82 % | $ 12.8 B | ||
|
Haemonetics Corporation
HAE
|
821 M | $ 59.93 | 0.52 % | $ 3.02 B | ||
|
electroCore
ECOR
|
-1.71 M | $ 6.18 | -0.08 % | $ 52.4 K | ||
|
ICU Medical
ICUI
|
2.12 B | $ 124.82 | 0.22 % | $ 3.08 B | ||
|
Envista Holdings Corporation
NVST
|
3.11 B | $ 26.8 | -0.89 % | $ 4.5 B | ||
|
Isoray
ISR
|
207 M | - | 0.03 % | $ 108 M | ||
|
Intuitive Surgical
ISRG
|
17.8 B | $ 482.22 | 0.71 % | $ 172 B | ||
|
Pulse Biosciences
PLSE
|
80.7 M | $ 23.02 | -5.07 % | $ 1.55 B | ||
|
Glaukos Corporation
GKOS
|
462 M | $ 121.48 | 0.5 % | $ 5.88 B | ||
|
Microbot Medical
MBOT
|
77.6 M | $ 2.2 | 0.92 % | $ 101 M | ||
|
STAAR Surgical Company
STAA
|
344 M | $ 25.67 | 3.34 % | $ 1.27 B | ||
|
STERIS plc
STE
|
6.6 B | $ 221.8 | -0.77 % | $ 21.9 B | ||
|
Masimo Corporation
MASI
|
1.05 B | $ 178.63 | -0.04 % | $ 9.52 B | ||
|
Milestone Scientific
MLSS
|
2.81 M | $ 0.32 | -1.27 % | $ 26.3 M | ||
|
InfuSystem Holdings
INFU
|
48 M | $ 10.34 | 0.68 % | $ 214 M | ||
|
Stereotaxis
STXS
|
13.5 M | $ 1.93 | -1.53 % | $ 176 M | ||
|
Merit Medical Systems
MMSI
|
1.58 B | $ 68.58 | -0.04 % | $ 4.06 B | ||
|
Teleflex Incorporated
TFX
|
3.12 B | $ 136.56 | -0.07 % | $ 6.09 B | ||
|
Utah Medical Products
UTMD
|
119 M | $ 67.17 | -1.03 % | $ 218 M | ||
|
West Pharmaceutical Services
WST
|
3.18 B | $ 306.16 | -1.14 % | $ 22.1 B | ||
|
DENTSPLY SIRONA
XRAY
|
1.34 B | $ 11.91 | 0.08 % | $ 2.37 B | ||
|
Retractable Technologies
RVP
|
74.4 M | $ 0.65 | 0.2 % | $ 19.5 M | ||
|
Pro-Dex
PDEX
|
36.6 M | $ 52.1 | 2.24 % | $ 171 M | ||
|
LeMaitre Vascular
LMAT
|
394 M | $ 113.45 | 0.49 % | $ 2.57 B | ||
|
Predictive Oncology
POAI
|
47.7 M | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
349 M | $ 21.38 | -1.57 % | $ 985 M | ||
|
Baxter International
BAX
|
6.13 B | $ 18.16 | -1.39 % | $ 9.32 B | ||
|
ResMed
RMD
|
3.36 B | $ 219.85 | 0.15 % | $ 32.1 B | ||
|
AtriCure
ATRC
|
492 M | $ 29.28 | 3.79 % | $ 1.4 B | ||
|
Harvard Bioscience
HBIO
|
13.7 M | $ 6.86 | 1.18 % | $ 305 M | ||
|
NeuroMetrix
NURO
|
14.3 M | - | 5.05 % | $ 9.02 M | ||
|
Becton, Dickinson and Company
BDX
|
25.4 B | $ 152.14 | -1.74 % | $ 43.8 B | ||
|
Nephros
NEPH
|
8.36 M | $ 2.87 | 1.06 % | $ 29.8 M | ||
|
OraSure Technologies
OSUR
|
341 M | $ 3.0 | -1.64 % | $ 220 M | ||
|
Repligen Corporation
RGEN
|
1.96 B | $ 117.6 | 3.1 % | $ 6.55 M |